fda stopping semaglutide FBI issues safety warning about counterfeit versions of weight loss drug New Novo Nordisk initiatives support

Mounjaro Mounjaro is a GLP-1 receptor agonist drug developed by Eli Lilly and Company

This approach is particularly appealing to those who might be sensitive to medication, aiming to avoid common side effects like nausea or gastrointestinal discomfort

The entire cost comes from your pocket

HFpEF is a specific type of heart failure in which the heart muscles stiffen and cannot properly fill with blood

Side Effects Explained Retatrutide, an investigational triple hormone receptor agonist targeting GLP-1, GIP, and glucagon receptors, has shown considerable promise for obesity and type 2 diabetes but can retatrutide make you dizzy